United Therapeutics (UTHR) director converts 650 RSUs into common stock holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp director Louis W. Sullivan reported the vesting of 650 restricted stock units on July 9, 2026, which converted on a one-for-one basis into 650 shares of common stock. Following the transaction, he holds 2,983 common shares directly and 867 common shares indirectly through a trust over which he has sole investment and voting power.
Positive
- None.
Negative
- None.
Insider Trade Summary
650 shares exercised/converted
Mixed
3 txns
Insider
SULLIVAN LOUIS W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 650 | $0.00 | -- |
| Exercise | Common Stock | 650 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 2,983 shares (Direct);
Common Stock — 867 shares (Indirect, by Trust)
Footnotes (1)
- Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. Not applicable as restricted stock units do not have an expiration date.
Key Figures
RSUs converted: 650 shares
Direct common shares after transaction: 2,983 shares
Indirect common shares via trust: 867 shares
+1 more
4 metrics
RSUs converted
650 shares
Restricted stock units converted one-for-one into common stock on July 9, 2026
Direct common shares after transaction
2,983 shares
Direct holdings of United Therapeutics common stock following RSU vesting
Indirect common shares via trust
867 shares
Common shares held indirectly by a trust with Sullivan having sole voting and investment power
Exercise price of RSUs
$0.0000 per share
Price per share for the RSU conversion into common stock
Key Terms
restricted stock units, derivative security, sole investment power
3 terms
restricted stock units financial
"Shares received upon vesting of restricted stock units on July 9, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Transaction code "M" indicates exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
sole investment power financial
"a trust over which the reporting person has sole investment power and sole voting power."
FAQ
What did UNITED THERAPEUTICS (UTHR) director Louis W. Sullivan report in this Form 4?
Louis W. Sullivan reported the vesting of 650 restricted stock units on July 9, 2026, which converted into an equal number of UNITED THERAPEUTICS common shares as part of his equity compensation.
What are Louis W. Sullivan’s total direct holdings of UNITED THERAPEUTICS (UTHR) after the Form 4 transactions?
After the reported transactions, Sullivan directly holds 2,983 shares of UNITED THERAPEUTICS common stock, reflecting the addition of 650 shares received from vested restricted stock units.
What does the Form 4 say about the expiration of Sullivan’s restricted stock units in UTHR?
The filing states that an expiration date is not applicable because restricted stock units do not have an expiration date, and in this case they vested and were converted into common stock.
Was Louis W. Sullivan’s UNITED THERAPEUTICS (UTHR) transaction an open-market buy or sell?
No. The reported activity is an exercise/conversion (code M) of restricted stock units into common shares, reflecting equity compensation vesting rather than an open-market purchase or sale.